scholarly article | Q13442814 |
P356 | DOI | 10.2337/DIABETES.51.5.1635 |
P698 | PubMed publication ID | 11978667 |
P2093 | author name string | Masaki Watanabe | |
Takuya Awata | |||
Kouichi Inukai | |||
Ikuo Inoue | |||
Shigehiro Katayama | |||
Susumu Kurihara | |||
Tomoko Ohkubo | |||
Kiyoaki Inoue | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | diabetic retinopathy | Q631361 |
type 2 diabetes | Q3025883 | ||
P1104 | number of pages | 5 | |
P304 | page(s) | 1635-1639 | |
P577 | publication date | 2002-05-01 | |
P1433 | published in | Diabetes | Q895262 |
P1476 | title | A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes | |
P478 | volume | 51 |
Q34445715 | A genome-wide association study for diabetic retinopathy in a Japanese population: potential association with a long intergenic non-coding RNA. |
Q63916411 | A genome-wide association study suggests new evidence for an association of the NADPH Oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes |
Q57971999 | An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy |
Q89534299 | Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study |
Q37437235 | Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma. |
Q35836668 | Association between a vascular endothelial growth factor gene polymorphism (rs2146323) and diabetic retinopathy: a meta-analysis |
Q35709085 | Association between the polymorphisms of the vascular endothelial growth factor gene and metabolic syndrome |
Q49490215 | Association between vascular endothelial growth factor promoter polymorphisms and the risk of recurrent implantation failure |
Q36638595 | Association of -2549 insertion/deletion polymorphism of vascular endothelial growth factor with breast cancer in North Indian patients. |
Q35532060 | Association of 18bp insertion/deletion polymorphism, at -2549 position of VEGF gene, with diabetic nephropathy in type 2 diabetes mellitus patients of North Indian population |
Q38925123 | Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease |
Q46350810 | Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North Indians. |
Q35078329 | Association of VEGF gene polymorphisms with diabetic retinopathy: a meta-analysis |
Q37660950 | Association of a vascular endothelial growth factor polymorphism with the development of bronchopulmonary dysplasia in Japanese premature newborns |
Q92405757 | Association of genetic polymorphism of vascular endothelial growth factor in the etiology of recurrent pregnancy loss: a triad study |
Q89660152 | Association of rs699947 (-2578 C/A) and rs2010963 (-634 G/C) Single Nucleotide Polymorphisms of the VEGF Gene, VEGF-A and Leptin Serum Level, and Cardiovascular Risk in Patients with Excess Body Mass: A Case-Control Study |
Q37035051 | Association of vascular endothelial growth factor (VEGF) +405 g>c polymorphism with endometriosis in an Iranian population |
Q37188104 | Association of vascular endothelial growth factor -634G/C and receptor for advanced glycation end products G82S gene polymorphisms with diabetic retinopathy |
Q81305854 | Association of vascular endothelial growth factor C-634 g polymorphism in taiwanese children with Kawasaki disease |
Q37121685 | Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. |
Q57797763 | Association of vascular endothelial growth factor expression and polymorphisms with the risk of gestational diabetes mellitus |
Q36854622 | Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer |
Q37321890 | Association of vascular endothelial growth factor polymorphisms with asthma in Tunisian children. |
Q88207082 | Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients |
Q84964231 | Association of vascular endothelial growth factor −634C/G polymorphism and diabetic retinopathy in type 2 diabetic Han Chinese |
Q50204127 | Bevacizumab-induced hypertension: Clinical presentation and molecular understanding |
Q43777380 | Breast Cancer Genomics Based on Biobanks |
Q35140894 | CFH, VEGF, and PEDF genotypes and the response to intravitreous injection of bevacizumab for the treatment of age-related macular degeneration |
Q28073127 | Candidate gene studies of diabetic retinopathy in human |
Q38143091 | Candidate genes for proliferative diabetic retinopathy |
Q26998699 | Challenges in elucidating the genetics of diabetic retinopathy |
Q81446293 | Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk |
Q37126546 | Comparative Evaluation for Potential Differentiation of Endothelial Progenitor Cells and Mesenchymal Stem Cells into Endothelial-Like Cells |
Q85356854 | Correlation of genetic polymorphism of vascular endothelial growth factor gene with susceptibility to lung cancer |
Q84702209 | Current evidence on VEGF+405G/C polymorphism and malignancy susceptibility: a meta-analysis involving 30 studies |
Q78419821 | Current literature in diabetes |
Q37477129 | Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population |
Q46727452 | Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. |
Q94038538 | Effect of Glucose on Retinal Endothelial Cell Viability and VEGF Secretion |
Q35158441 | Effect of Stress-free Therapy on Cerebral Blood Flow: Comparisons among patients with metabolic cardiovascular disease, healthy subjects and placebo-treated subjects |
Q32177710 | Ethnic differences in the +405 and -460 vascular endothelial growth factor polymorphisms and peripheral neuropathy in patients with diabetes residing in a North London, community in the United Kingdom. |
Q41192013 | Evaluation of VEGF gene polymorphisms and proliferative diabetic retinopathy in Mexican population. |
Q33849608 | Fetal Vegf Genotype is More Important for Abortion Risk than Mother Genotype |
Q36914007 | Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy |
Q35009074 | Four common vascular endothelial growth factor polymorphisms (-2578C>A, -460C>T, +936C>T, and +405G>C) in susceptibility to lung cancer: a meta-analysis |
Q37667504 | Four polymorphisms of VEGF (+405C>G, -460T>C, -2578C>A, and -1154G>A) in susceptibility to psoriasis: a meta-analysis |
Q35638444 | Gene set enrichment analysis of pathways and transcription factors associated with diabetic retinopathy using a microarray dataset |
Q42087723 | Genetic Risk Factors for Psoriasis in Turkish Population: -1540 C/A, -1512 Ins18, and +405 C/G Polymorphisms within the Vascular Endothelial Growth Factor Gene |
Q26801676 | Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies |
Q36250613 | Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications |
Q88481159 | Genetic and epigenetic modifications in the pathogenesis of diabetic retinopathy: a molecular link to regulate gene expression |
Q37090696 | Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk |
Q45900950 | Genetic polymorphisms of vascular endothelial growth factor and risk for retinopathy of prematurity in South of Iran. |
Q37217851 | Genetic susceptibility of diabetic retinopathy. |
Q35912389 | Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study |
Q37148800 | Genetics in diabetic retinopathy: current concepts and new insights |
Q33828717 | Genetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphisms. |
Q37310665 | Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis |
Q36225882 | Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS |
Q35870130 | High prevalence of diabetic retinopathy and lack of association with integrin α2 gene polymorphisms in patients with type 2 diabetes from Northeastern Mexico |
Q38247113 | Human genetics of diabetic retinopathy |
Q34035397 | Human genetics of diabetic retinopathy: current perspectives |
Q27000709 | Human genetics of diabetic vascular complications |
Q35354678 | Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels |
Q46960662 | Impact of VEGFA polymorphisms on glioma risk in Chinese |
Q46532695 | Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy |
Q54526233 | Increase levels of apo-A1 and apo B are associated in knee osteoarthritis: lack of association with VEGF-460 T/C and +405 C/G polymorphisms. |
Q90284109 | Inhibition of Receptor for Advanced Glycation End Products as New Promising Strategy Treatment in Diabetic Retinopathy |
Q40361784 | Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. |
Q43179296 | Interleukin-13 and interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells: role of vascular endothelial growth factor genotype |
Q39378686 | Investigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case-control study |
Q54545150 | Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasaki disease in Taiwanese children. |
Q36803708 | Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy |
Q36072409 | Meta analysis on the relationship between gene polymorphisms of vascular endothelial growth factor and retinal prognosis risk of prematurity |
Q37417261 | Molecular profiling of sinonasal undifferentiated carcinoma |
Q38865936 | Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss. |
Q54562952 | No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population. |
Q28565784 | Overexpression of nuclear transport factor 2 may protect against diabetic retinopathy |
Q38166233 | Personalizing colon cancer therapeutics: targeting old and new mechanisms of action. |
Q45791377 | Polymorphism of VEGF-2578C/A associated with the risk and aggressiveness of nasopharyngeal carcinoma in a Chinese population |
Q85195840 | Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril |
Q43807701 | Polymorphisms in the 5′- and 3′-untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics |
Q35600012 | Polymorphisms in the vascular endothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes. |
Q33645770 | Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)-a retrospective case-control study |
Q37728387 | Polymorphisms of VEGFA gene and susceptibility to hemorrhage risk of brain arteriovenous malformations in a Chinese population. |
Q35914668 | Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy |
Q43421738 | Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab |
Q37521976 | Prevalence of +405G>C,-1154G>A Vascular Endothelial Growth Factor Polymorphism in Breast Cancer |
Q37187766 | Prognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer |
Q54284662 | Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer. |
Q37479727 | RETRACTED: Investigation of the hub genes and related mechanism in ovarian cancer via bioinformatics analysis |
Q34466706 | Relationship between single nucleotide polymorphisms in the 3'-untranslated region of the vascular endothelial growth factor gene and susceptibility to diabetic peripheral neuropathy in China |
Q51021068 | Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes. |
Q54273203 | Role of NF-κB activation and VEGF gene polymorphisms in VEGF up regulation in non-proliferative and proliferative diabetic retinopathy. |
Q33817206 | Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation |
Q87713814 | Role of the VEGF 936 gene polymorphism and VEGF-A levels in the late-term arteriovenous fistula thrombosis in patients undergoing hemodialysis |
Q42672858 | SNP and Haplotype Analysis of Vascular Endothelial Growth Factor (VEGF) Gene in Lung Cancer Patients of Kashmir |
Q42181735 | SNP rs2073618 of the osteoprotegerin gene is associated with diabetic retinopathy in Slovenian patients with type 2 diabetes |
Q35934127 | Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies |
Q47194606 | Tang Wang Ming Mu Granule Attenuates Diabetic Retinopathy in Type 2 Diabetes Rats |
Q55260806 | The -2549 insertion/deletion polymorphism in the promoter region of VEGF is associated with the risk of recurrent spontaneous abortion. |
Q94465359 | The Association Analysis of Vascular Endothelial Growth Factor -2549 Insertion/ Deletion Variant and Endometriosis Risk |
Q55405709 | The association between MCP-1, VEGF polymorphisms and their serum levels in patients with diabetic foot ulcer. |
Q41761756 | The association between VEGF -634C/G polymorphisms and osteonecrosis of femoral head: a meta-analysis. |
Q84615969 | The association of single nucleotide polymorphism within vascular endothelial growth factor gene with systemic lupus erythematosus and lupus nephritis |
Q26823178 | The associations between VEGF gene polymorphisms and diabetic retinopathy susceptibility: a meta-analysis of 11 case-control studies |
Q33342892 | The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity |
Q37738769 | The expanding role of bevacizumab in the treatment of human epidermal growth factor receptor 2-negative breast cancer |
Q36977441 | The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice. |
Q38396875 | The genetics of diabetic complications |
Q51430093 | The impact of vascular endothelial growth factor +405 C/G polymorphism on long-term outcome and severity of coronary artery disease. |
Q50501371 | The joint effect of the endothelin receptor B gene (EDNRB) polymorphism rs10507875 and nitric oxide synthase 3 gene (NOS3) polymorphism rs869109213 in Slovenian patients with type 2 diabetes mellitus and diabetic retinopathy. |
Q48148975 | The relationship between ACE/AGT gene polymorphisms and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes |
Q34572068 | The relationship of vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer |
Q40214804 | The role of NOS2A -954G/C and vascular endothelial growth factor +936C/T polymorphisms in type 2 diabetes mellitus and diabetic nonproliferative retinopathy risk management. |
Q34450594 | The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization |
Q24651324 | The role of genetics in susceptibility to diabetic retinopathy |
Q54373570 | The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus. |
Q26851522 | The role of vascular endothelial growth factor a polymorphisms in breast cancer |
Q35019229 | Two polymorphisms (rs699947, rs2010963) in the VEGFA gene and diabetic retinopathy: an updated meta-analysis |
Q80599380 | VEGF C-634G polymorphism is associated with protection from isolated ventricular septal defect: case-control and TDT studies |
Q36287686 | VEGF Gene Polymorphisms are Associated with Risk of Tetralogy of Fallot |
Q93113040 | VEGF Promoter Region 18-bp Insertion-Deletion Polymorphism in Sickle Cell Disease Patients with Microalbuminuria: A Pilot Study |
Q36541140 | VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese |
Q43110034 | VEGF and IL-4 gene variability and its association with the risk of coronary heart disease in north Indian population. |
Q36746698 | VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib |
Q41953798 | VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma. |
Q84534882 | VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration |
Q54513599 | VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. |
Q61943929 | VEGF gene variability and type 1 diabetes: evidence for a protective role |
Q45863485 | VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death |
Q35448592 | VEGF polymorphisms and severity of atherosclerosis. |
Q47243737 | VEGF-A gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema. |
Q45857957 | VEGF: a modifier of the del22q11 (DiGeorge) syndrome? |
Q41714150 | VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab. |
Q36529712 | Vascular Endothelial Growth Factor Gene Polymorphism (rs2010963) and Its Receptor, Kinase Insert Domain-Containing Receptor Gene Polymorphism (rs2071559), and Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus |
Q51674209 | Vascular Endothelial Growth Factor Gene Polymorphisms in Japanese Patients With Sarcoidosis |
Q84792949 | Vascular Endothelial Growth Factor Gene Polymorphisms in Susceptibility to Coronary Artery Disease |
Q54331504 | Vascular endothelial growth factor (VEGF) +405 C/G polymorphism is associated with essential hypertension in a population from Tehran of Iran. |
Q35689605 | Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? |
Q64226448 | Vascular endothelial growth factor (VEGF)-related polymorphisms rs10738760 and rs6921438 are not risk factors for proliferative diabetic retinopathy (PDR) in patients with type 2 diabetes mellitus (T2DM) |
Q47162425 | Vascular endothelial growth factor (VEGF)-related single nucleotide polymorphisms rs10738760 and rs6921438 are not associated with diabetic retinopathy (DR) in Slovenian patients with type 2 diabetes mellitus (T2DM). |
Q43973274 | Vascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case-control study and meta-analysis |
Q85059698 | Vascular endothelial growth factor 1498C/T, 936C/T polymorphisms associated with increased risk of colorectal adenoma: a Chinese case-control study |
Q33817641 | Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia |
Q83200227 | Vascular endothelial growth factor A gene (VEGFA) polymorphisms and expression of VEGFA gene in lung cancer patients of Kashmir Valley (India) |
Q38692303 | Vascular endothelial growth factor A polymorphisms are associated with increased risk of coronary heart disease: a meta-analysis |
Q37221880 | Vascular endothelial growth factor and hypoxia-inducible factor-1α gene polymorphisms and coronary collateral formation in patients with coronary chronic total occlusions |
Q35537490 | Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome. |
Q40982952 | Vascular endothelial growth factor gene polymorphisms and association with age related macular degeneration in Indian patients |
Q57306045 | Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival |
Q34938869 | Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis |
Q49825699 | Vascular endothelial growth factor gene variations as a risk predictor in disc degeneration. |
Q34092050 | Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population |
Q34775945 | Vascular endothelial growth factor genotypes and haplotypes contribute to the susceptibility of obstructive sleep apnea syndrome |
Q84272251 | Vascular endothelial growth factor polymorphisms and extent of coronary atherosclerosis in Chinese population with advanced coronary artery disease |
Q37565250 | Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility |
Q82066671 | Vascular endothelial growth factor-A gene polymorphisms in women with recurrent pregnancy loss |
Q38418718 | Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease |
Q46714484 | WITHDRAWN: Single nucleotide polymorphisms, haplotype association and tumour expression of the vascular endothelial growth factor (VEGF) gene with lung carcinoma |
Q53732831 | Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy. |
Q80134411 | [Genetics of diabetic complications: retinopathy] |
Search more.